Toward reaching hepatitis B goals: hepatitis B epidemiology and the impact of two decades of vaccination, Georgia, 2021
ConclusionsHepatitis B vaccination in Georgia had remarkable impact. In 2021, HBsAg prevalence among children was well below the 0.5% hepatitis B control target of the European Region and met the ≤ 0.1% HBsAg seroprevalence target for elimination of mother-to-child transmission of HBV. Chronic HBV infection remains a problem among adults born before vaccine introduction. Screening, treatment and preventive interventions among adults, and sustained high immunisation coverage among children, can help eliminate hepatitis B in Georgia by 2030.PMID:37498531 | PMC:PMC10375835 | DOI:10.2807/1560-7917.ES.2023.28.30.2200837
Source: Euro Surveill - Category: Infectious Diseases Authors: Nino Khetsuriani Amiran Gamkrelidze Shaun Shadaker Maia Tsereteli Maia Alkhazashvili Nazibrola Chitadze Irina Tskhomelidze Lia Gvinjilia Francisco Averhoff Gavin Cloherty Qian An Giorgi Chakhunashvili Jan Drobeniuc Paata Imnadze Khatuna Zakhashvili Paige Source Type: research
More News: Children | Epidemiology | Georgia Health | Hepatitis | Hepatitis A | Hepatitis B | Hepatitis Vaccine | Infectious Diseases | International Medicine & Public Health | Vaccines | WHO